-
1
-
-
4344684441
-
Pharmacogenetics and drug development: The path to safer and more effective drugs
-
DOI 10.1038/nrg1432
-
Roses AD. Pharmacogenetics and Drug Development: The Path to safer and more effective Drugs. Nature Rev 2004;5:645-56. (Pubitemid 39150121)
-
(2004)
Nature Reviews Genetics
, vol.5
, Issue.9
, pp. 645-656
-
-
Roses, A.D.1
-
2
-
-
0027446505
-
The P450 superfamily: Update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature
-
Nelson DR, Kamataki T, Waxman DJ et al. The P450 superfamily: Update on new sequences, gene mapping, accession numbers, early trivial names of enzymes and nomenclature. DNA Cell Biol 1993;12:1-51. (Pubitemid 23064489)
-
(1993)
DNA and Cell Biology
, vol.12
, Issue.1
, pp. 1-51
-
-
Nelson, D.R.1
Kamataki, T.2
Waxman, D.J.3
Guengerich, F.P.4
Estabrook, R.W.5
Feyereisen, R.6
Gonzalez, F.J.7
Coon, M.J.8
Gunsalus, I.C.9
Gotoh, O.10
Okuda, K.11
Nebert, D.W.12
-
3
-
-
10544248170
-
The cytochrome P450 2D6 (CYP2D6) enzyme polymorphism: Screening costs and influence on clinical outcomes in psychiatry
-
Chen S, Chou WH, Blouin RA et al. The cytochrome P450 2D6 (CYP2D6) enzyme polymorphism: Screening costs and influence in clinical outcomes in psychiatry. Clin Pharmacol Ther 1996;60:522-34. (Pubitemid 26414088)
-
(1996)
Clinical Pharmacology and Therapeutics
, vol.60
, Issue.5
, pp. 522-534
-
-
Chen, S.1
Chou, W.-H.2
Blouin, R.A.3
Mao, Z.4
Humphries, L.L.5
Meek, Q.C.6
Neill, J.R.7
Martin, W.L.8
Hays, L.R.9
Wedlund, P.J.10
-
4
-
-
0029055448
-
Phenotyping and genotyping of S-mephenytoin hydroxylase (cytochrome P450 2C19) in a Shona population of Zimbabwe
-
Masimirembwa C, Bertilsson L, Johnansson I, Hasler JA, Ingelman-Sundberg M. Phenotyping and genotyping of S-mephenytoin hydroxylase (cytochrome P450 2C19) in a Shona population of Zimbabwe. Clin Pharmacol Ther 1995;57:656-61.
-
(1995)
Clin Pharmacol Ther
, vol.57
, pp. 656-661
-
-
Masimirembwa, C.1
Bertilsson, L.2
Johnansson, I.3
Hasler, J.A.4
Ingelman-Sundberg, M.5
-
5
-
-
1842825630
-
Genetic analysis of the human cytochrome P450 CYP2C9 locus
-
Stubbins MJ, Harris LW, Smith G, Tarbit MH, Wolf CR. Genetic analysis of the human cytochrome P450 CYP2C9 locus. Pharmacogenetics 1997;7:59-64.
-
(1997)
Pharmacogenetics
, vol.7
, pp. 59-64
-
-
Stubbins, M.J.1
Harris, L.W.2
Smith, G.3
Tarbit, M.H.4
Wolf, C.R.5
-
6
-
-
0036889666
-
CYP2C8 polymorphisms in Caucasians and their relationship with paclitaxel 6alpha-hydroxylase activity in human liver microsomes
-
DOI 10.1016/S0006-2952(02)01354-0, PII S0006295202013540
-
Bahadur N, Leathart JB, Mutch E, et al. CYP2C8 polymorphisms in Caucasians and their relationship with paclitaxel 6-alpha-hydroxylase activity in human liver microsomes. Biochem Pharmacol 2002;64:1579-89. (Pubitemid 35333419)
-
(2002)
Biochemical Pharmacology
, vol.64
, Issue.11
, pp. 1579-1589
-
-
Bahadur, N.1
Leathart, J.B.S.2
Mutch, E.3
Steimel-Crespi, D.4
Dunn, S.A.5
Gilissen, R.6
Houdt, J.V.7
Hendrickx, J.8
Mannens, G.9
Bohets, H.10
Williams, F.M.11
Armstrong, M.12
Crespi, C.L.13
Daly, A.K.14
-
7
-
-
0034792584
-
Clinical relevance of genetic polymorphisms in the human CYP2C subfamily
-
DOI 10.1046/j.0306-5251.2001.01499.x
-
Goldstein JA. Clinical relevance of genetic polymorphisms in human CYP2C subfamily. Br J Clin Pharmacol 2001; 52:349-55. (Pubitemid 32939439)
-
(2001)
British Journal of Clinical Pharmacology
, vol.52
, Issue.4
, pp. 349-355
-
-
Goldstein, J.A.1
-
8
-
-
0037328994
-
Pharmacogenetics of the major polymorphic metabolizing enzymes
-
DOI 10.1046/j.1472-8206.2003.00119.x
-
Daly AK. Pharmacogenetics of the major polymorphic metabolizing enzymes. Fundam Clin Pharmacol 2003;17:27-41. (Pubitemid 36241451)
-
(2003)
Fundamental and Clinical Pharmacology
, vol.17
, Issue.1
, pp. 27-41
-
-
Daly, A.K.1
-
9
-
-
0030841936
-
Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism
-
DOI 10.1016/S0300-9084(97)81496-4
-
Latruffe N, Vamecq J. Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism. Biochimie 1997;79:81-94. (Pubitemid 27290347)
-
(1997)
Biochimie
, vol.79
, Issue.2-3
, pp. 81-94
-
-
Latruffe, N.1
Vamecq, J.2
-
10
-
-
33644918580
-
Pioglitazone: An antidiabetic drug with the potency to reduce cardiovascular mortality
-
DOI 10.1517/14656566.7.4.463
-
Pfützner A, Forst T. Pioglitazone, an anti-diabetic drug with the potency to reduce cardiovascular mortality. Expert Opin Pharmacother. 2006;7:463-76. (Pubitemid 43379612)
-
(2006)
Expert Opinion on Pharmacotherapy
, vol.7
, Issue.4
, pp. 463-476
-
-
Pfutzner, A.1
Forst, T.2
-
11
-
-
0002103003
-
PPARgamma agonists in type 2 diabetes: How far have we come in 'preventing the inevitable'? - A review of the metabolic effects of rosiglitazone
-
Zinman B. PPAR gamma agonists in type 2 diabetes: how far have we come in 'preventing the inevitable'? A review of the metabolic effects of rosiglitazone. Diabetes Obes Metab. 2001;3(Suppl 1):S34-43. (Pubitemid 33720704)
-
(2001)
Diabetes, Obesity and Metabolism
, vol.3
, Issue.SUPPL. 1
-
-
Zinman, B.1
-
12
-
-
33845350116
-
A fast and reliable single-run method for genotyping of the human cytochrome P450 2C8 gene for different ethnic groups
-
Weise A, Lambertz U, Thomé N, et al. (2006) A fast and reliable single-run method for genotyping of the human cytochrome P450 2C8 gene for different ethnic groups. Clin Lab. 2006;52(11-12):599-603. (Pubitemid 44883587)
-
(2006)
Clinical Laboratory
, vol.52
, Issue.11-12
, pp. 599-603
-
-
Weise, A.1
Lambertz, U.2
Thome, N.3
Bartz, U.4
Krefft, M.5
Mockenhaupt, F.6
Bienzle, U.7
Schondorf, T.8
Forst, T.9
Pfutzner, A.10
-
13
-
-
0036720991
-
Rapid and reliable method for cytochrome P450 2D6 genotyping
-
Stamer UM, Bayerer B, Wolf S, Hoeft A, Stüber F. et al. (2002) Rapid and Reliable Method for Cytochrome P450 2D6 Genotyping. Clin Chem. 2002 Sep;48(9):1412-7. (Pubitemid 34925775)
-
(2002)
Clinical Chemistry
, vol.48
, Issue.9
, pp. 1412-1417
-
-
Stamer, U.M.1
Bayerer, B.2
Wolf, S.3
Hoeft, A.4
Stuber, F.5
-
14
-
-
17444453992
-
Optimized strategy for rapid cytochrome P450 2D6 genotyping by real-time long PCR
-
DOI 10.1373/49.10.1624
-
Müller B, Zöpf K, Bachofer J, Steimer W. et al. (2003) Optimized strategy for rapid cytochrome P450 2D6 genotyping by real-time long PCR. Clin Chem. 2003 Oct;49 (10):1624-31. (Pubitemid 37194216)
-
(2003)
Clinical Chemistry
, vol.49
, Issue.10
, pp. 1624-1631
-
-
Muller, B.1
Zopf, K.2
Bachofer, J.3
Steimer, W.4
-
15
-
-
0034791777
-
Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid
-
DOI 10.1097/00008571-200110000-00006
-
Dai D, Zeldin DC, Blaisdell JA, et al. Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid. Pharmacogenetics 2001;11:597-607. (Pubitemid 32953585)
-
(2001)
Pharmacogenetics
, vol.11
, Issue.7
, pp. 597-607
-
-
Dai, D.1
Zeldin, D.C.2
Blaisdell, J.A.3
Chanas, B.4
Coulter, S.J.5
Ghanayem, B.I.6
Goldstein, J.A.7
-
16
-
-
48849098300
-
Functional role of Ile264 in CYP2C8: Mutations affect haem incorporation and catalytic activity
-
Singh R, Ting JG, Pan Y, Teh LK, Ismail R, Ong CE. Functional role of Ile264 in CYP2C8: mutations affect haem incorporation and catalytic activity. Drug Metab Pharmacokinet. 2008;23:165-174.
-
(2008)
Drug Metab Pharmacokinet.
, vol.23
, pp. 165-174
-
-
Singh, R.1
Ting, J.G.2
Pan, Y.3
Teh, L.K.4
Ismail, R.5
Ong, C.E.6
-
17
-
-
34548330055
-
Rosiglitazone for type 2 diabetes mellitus
-
CD006063
-
Richter B, Bandeira-Echtler E, Bergerhoff K, Clar C, Ebrahim SH. Rosiglitazone for type 2 diabetes mellitus. Cochrane Database Syst Rev. 2007;18:CD006063.
-
(2007)
Cochrane Database Syst Rev.
, vol.18
-
-
Richter, B.1
Bandeira-Echtler, E.2
Bergerhoff, K.3
Clar, C.4
Ebrahim, S.H.5
-
20
-
-
29044443860
-
High prevalence of the cytochrome P450 2C8*2 mutation in Northern Ghana
-
DOI 10.1111/j.1365-3156.2005.01525.x
-
Röwer S., Bienzle U., Weise A., et al. High prevalence of cytochrome P450 2C8*2 mutation in northern Ghana. Trop. Med. Int. Health 2005;10:1271-3. (Pubitemid 41789681)
-
(2005)
Tropical Medicine and International Health
, vol.10
, Issue.12
, pp. 1271-1273
-
-
Rower, S.1
Bienzle, U.2
Weise, A.3
Lambertz, U.4
Forst, T.5
Otchwemah, R.N.6
Pfutzner, A.7
Mockenhaupt, F.P.8
-
21
-
-
53249103537
-
Relationship between CYP2C8 genotypes and diclofenac 5-hydroxylation in healthy Spanish volunteers
-
Dorado P, Cavaco I, Cáceres MC, Piedade R, Ribeiro V, Llerena A. Relationship between CYP2C8 genotypes and diclofenac 5-hydroxylation in healthy Spanish volunteers. Eur J Clin Pharmacol. 2008;64:967-70.
-
(2008)
Eur J Clin Pharmacol.
, vol.64
, pp. 967-970
-
-
Dorado, P.1
Cavaco, I.2
Cáceres, M.C.3
Piedade, R.4
Ribeiro, V.5
Llerena, A.6
-
22
-
-
35548988485
-
Pharmacogenetics of glucose-lowering drug treatment: A systematic review
-
Bozkurt O, de Boer A, Grobbee DE, Heerdink ER, Burger H, Klungel OH. Pharmacogenetics of glucose-lowering drug treatment: a systematic review. Mol Diagn Ther. 2007;11(5):291-302. (Pubitemid 350014793)
-
(2007)
Molecular Diagnosis and Therapy
, vol.11
, Issue.5
, pp. 291-302
-
-
Bozkurt, O.1
De Boer, A.2
Grobbee, D.E.3
Heerdink, E.R.4
Burger, H.5
Klungel, O.H.6
|